Murine dorsal air pouch model

CT C. Trilleaud
VG V. Gauttier
KB K. Biteau
IG I. Girault
LB L. Belarif
CM C. Mary
SP S. Pengam
GT G. Teppaz
VT V. Thepenier
RD R. Danger
GR G. Robert-Siegwald
MN M. Néel
SB S. Bruneau
AG A. Glémain
AN A. Néel
AP A. Poupon
JM J. F. Mosnier
GC G. Chêne
MD M. Dubourdeau
GB G. Blancho
BV B. Vanhove
NP N. Poirier
request Request a Protocol
ask Ask a question
Favorite

Dorsal air pouches were formed on male Balb/c mice (6 to 8 weeks old) by injecting subcutaneously 3 ml of sterile air in day 0 and day 3. Mice were then intraperitoneally injected with anti-ChemR23 mAb or hIgG1 control mAb at 1 mg/kg or with RvE1 (50 μg/kg) on successive days at d5 and d6. On day 6, inflammation was induced by intrapouch injection of recombinant murine TNF (50 ng) or carrageenan (1%/1 ml per pouch). Pouch lavages (PBS-EDTA 2 mM) were collected at 4, 8, 24, or 48 hours, and cells were stained for phenotyping by flow cytometry. F4/80 (BM8), Ly6G (1A8), and anti-mouse ChemR23 (clone 477806) were used to identify macrophages, PMN, and ChemR23 expression, respectively. PMN mortality was evaluated with a viability dye (Life Technologies). The extraction protocol and analysis of bioactive lipids were performed as previously described (88) and adapted according to the Ambiotis SAS (Toulouse, France) standard operating procedure. The liquid chromatography–tandem mass spectrometry experiment was performed on an ExionLC™ AD Ultra-High-Performance Liquid Chromatography system (Sciex) coupled to a QTRAP 6500+ MS (Sciex) and equipped with electrospray ionization source and performed in negative ion mode.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A